Not satisfied with simply changing personnel, Japanese drugmaker Astellas has announced a new management structure, effective ...

The bill's supporters framed it as part of the solution to addressing both high drug prices and slowing the pace of pharmacy ...

Astellas has changed its management structure, establishing new top management positions and making personnel changes. The goal of the change is to promote drug discovery activities swiftly and ...

Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...

Hanmi Pharmaceutical posts record sales of 1.5 trillion won, profits decline Hanmi Pharmaceutical achieves record earnings while profit margins experience a downturn ...

Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...

Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasised the importance of regulatory harmonisation in ensuring patient safety and ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the following changes to its management structure effective April 1, 2025.

TAMPA, FL / ACCESS Newswire / February 3, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) is pleased to announce a reduction in its authorized share count by 150 million shares. CTT reduced the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

As global markets navigate a mix of steady interest rates, fluctuating corporate earnings, and geopolitical uncertainties, investors are seeking opportunities in less conventional areas. Penny stocks, ...